Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8HQT

The complex structure of COPI cargo sorting module with SARS-CoV-2 Spike KxHxx sorting motif

Summary for 8HQT
Entry DOI10.2210/pdb8hqt/pdb
DescriptorCoatomer subunit beta', SARS-CoV-2 Spike KxHxx motif (3 entities in total)
Functional Keywordssars-cov-2, spike, copi vesicle, kxhxx motif, retention signal, transport protein
Biological sourceSaccharomyces cerevisiae (strain YJM789) (Baker's yeast)
More
Total number of polymer chains2
Total formula weight35055.56
Authors
Ma, W.F.,Nan, Y.N.,Yang, M.R.,Li, Y.Q. (deposition date: 2022-12-14, release date: 2023-12-20, Last modification date: 2025-01-29)
Primary citationLi, Y.,Yang, M.,Nan, Y.,Wang, J.,Wang, S.,Cui, D.,Guo, J.,He, P.,Dai, W.,Zhou, S.,Zhang, Y.,Ma, W.
SARS-CoV-2 spike host cell surface exposure promoted by a COPI sorting inhibitor.
Acta Pharm Sin B, 13:3043-3053, 2023
Cited by
PubMed Abstract: an insufficient coat protein complex I (COPI) retrieval signal, the majority of SARS-CoV-2 spike (S) is resident in host early secretory organelles and a tiny amount is leaked out in cell surface. Only surface-exposed S can be recognized by B cell receptor (BCR) or anti-S therapeutic monoclonal antibodies (mAbs) that is the trigger step for B cell activation after S mRNA vaccination or infected cell clearance by S mAbs. Now, a drug strategy to promote S host surface exposure is absent. Here, we first combined structural and biochemical analysis to characterize S COPI sorting signals. A potent S COPI sorting inhibitor was then invented, evidently capable of promoting S surface exposure and facilitating infected cell clearance by S antibody-dependent cellular cytotoxicity (ADCC). Importantly, with the inhibitor as a probe, we revealed Omicron BA.1 S is less cell surface exposed than prototypes because of a constellation of S folding mutations, possibly corresponding to its ER chaperone association. Our findings not only suggest COPI is a druggable target against COVID-19, but also highlight SARS-CoV-2 evolution mechanism driven by S folding and trafficking mutations.
PubMed: 37360012
DOI: 10.1016/j.apsb.2023.04.007
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon